NCT04604678: A trial that was reported late by AgelessRx
This trial was previously reported as an Applicable Clinical Trial, but is no longer.
Full data
| Full entry on ClinicalTrials.gov | NCT04604678 |
|---|---|
| Title | Pilot Study Into the Use of Metformin and Low Dose Naltrexone (LDN) for Patients With Coronavirus Disease 2019 (COVID-19) - Assessment of Short and Long Term Effects |
| Results Status | no-longer-act |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Feb. 28, 2021 |
| Completion date | Aug. 31, 2021 |
| Required reporting date | Aug. 31, 2022, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Oct. 5, 2022 |
| Days late | 34 |